Latest Articles
Merck posts late-stage trial win for frontline Keytruda in endometrial cancer - MSN
Merck posts late-stage trial win for frontline Keytruda in endometrial cancer MSN
Published: July 15, 2026, 6:22 p.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Benzinga
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Benzinga
Published: July 15, 2026, 5:25 p.m.
Clinical and surgical diagnosis of endometriosis, with Heather Appelbaum, MD - Contemporary OB/GYN
Clinical and surgical diagnosis of endometriosis, with Heather Appelbaum, MD Contemporary OB/GYN
Published: July 15, 2026, 5:16 p.m.
GSK Advances New Maintenance Therapy Trial in Endometrial Cancer, Adding Depth to Its Oncology Pipeline - TipRanks
GSK Advances New Maintenance Therapy Trial in Endometrial Cancer, Adding Depth to Its Oncology Pipeline TipRanks
Published: July 15, 2026, 4:46 p.m.
US Says Ceasefire Is Holding Despite Iran's Attacks In The Strait Of Hormuz And Against The UAE Endometriosis (t3A5vggIfI) - Mshale
US Says Ceasefire Is Holding Despite Iran's Attacks In The Strait Of Hormuz And Against The UAE Endometriosis (t3A5vggIfI) Mshale
Published: July 15, 2026, 4:26 p.m.
Two tests GPs can soon offer to help spot endometriosis - AOL.com
Two tests GPs can soon offer to help spot endometriosis AOL.com
Published: July 15, 2026, 4:06 p.m.
Rethinking Endometriosis: A Whole-Body Disease - Yale Medicine
Rethinking Endometriosis: A Whole-Body Disease Yale Medicine
Published: July 15, 2026, 4:01 p.m.
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer - OncLive
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer OncLive
Published: July 15, 2026, 3:58 p.m.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace
Published: July 15, 2026, 3:11 p.m.
Simple Androgen Blood Test Could Identify Endometriosis With 95% Accuracy - Health and Me
Simple Androgen Blood Test Could Identify Endometriosis With 95% Accuracy Health and Me
Published: July 15, 2026, 12:30 p.m.
Link copied to clipboard!